Verastem | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (39)

View All

Latest Posts

About This Stock More About This Stock
10 Best Medical Stocks Under $5
Article By: Insider Monkey
Saturday, October 29, 2022 4:34 PM EDT
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the pace with technology.
In this article: GERN, HOOK, AGEN, CTIC, KPTI, VSTM, ARDX, TTOO, XERS, ZOM
Read
The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference
Article By: Benzinga
Sunday, September 13, 2020 2:40 PM EDT
Biotech stocks continued to remain under pressure in the week ended September 11, swayed by the volatility that was evident in the broader market. The week also witnessed a flurry of news flow on the coronavirus vaccine front.
In this article: AZN, IMMP, ALKS, CLVS, AGEN, PRTA, VSTM, MRSN, BHC, ETON
Read
2019 Should Be A Good Year For Trevena, But What’s Next?
Article By: Zion Miller
Wednesday, February 6, 2019 4:09 PM EDT
Trevena Inc. spiked 119% from the $.5 range to $1.19 on January 28th. The catalyst being positive regulatory updates from the FDA
In this article: TRVN Also: VSTM, ACRX
Read
Morning Call For Wednesday, May 16
Article By: Jim Van Meerten
Wednesday, May 16, 2018 7:54 AM EDT
Jun E-mini S&Ps (ESM18 +0.07%) this morning are up +0.07% as T-note yields stabilize.
In this article: ABR, MON, BMRN, BOOT, PSEC, MU, TEVA, TRIP, VSTM, OLLI, GEMP, CYAD, PETQ
Read
Morning Call For Friday, Dec. 15
Article By: Jim Van Meerten
Friday, December 15, 2017 9:02 AM EDT
March E-mini S&Ps (ESH18 +0.22%) this morning are up +0.16% and European stocks are down -0.34% at a 1-week low. Investors continue to pour money into U.S. equity funds at the expense of European stock funds.
In this article: CNC, DDR, HES, JBL, ADBE, DISCA, FORM, ORCL, RPAI, TMUS, VSTM, GBT
Read
All Posts

Latest Tweets for $VSTM

No tweets yet!

PARTNER HEADLINES